Vitamin D3 (Cholecalciferol): Uses, Dosage & Side Effects
Essential vitamin for calcium regulation, bone health, and immune function
Quick Facts About Vitamin D3
Key Takeaways About Vitamin D3
- Essential for bone health: Vitamin D3 regulates calcium absorption from the gut and promotes mineralization of bone tissue, helping prevent osteoporosis and fractures
- Widespread deficiency: An estimated 1 billion people worldwide have vitamin D deficiency or insufficiency, particularly those with limited sun exposure, darker skin, or who live at higher latitudes
- Standard dose is 800 IU daily: The recommended prescription dose for treating and preventing deficiency in adults is one 800 IU tablet per day, with a maximum of 4,000 IU daily
- Few side effects at recommended doses: Side effects are uncommon when vitamin D3 is taken as directed; however, excessive intake can cause dangerously high blood calcium (hypercalcemia)
- Important drug interactions: Cholestyramine, phenytoin, corticosteroids, thiazide diuretics, and orlistat can all affect vitamin D3 levels or increase the risk of side effects
What Is Vitamin D3 (Cholecalciferol) and What Is It Used For?
Vitamin D3 (cholecalciferol) is a fat-soluble vitamin that regulates calcium and phosphate metabolism in the body. It promotes calcium absorption from the intestine, supports bone mineralization, and helps maintain healthy calcium levels in the blood. It is prescribed to prevent and treat vitamin D deficiency in adults and adolescents, and as an adjunct to specific osteoporosis treatments.
Vitamin D3, also known as cholecalciferol or colecalciferol, is the naturally occurring form of vitamin D that is produced in the skin when it is exposed to ultraviolet B (UVB) radiation from sunlight. It belongs to the group of fat-soluble vitamins and plays a fundamental role in calcium and phosphate homeostasis. Once ingested or synthesized in the skin, cholecalciferol undergoes two hydroxylation steps: first in the liver to form calcifediol (25-hydroxyvitamin D), the main circulating form used to assess vitamin D status, and then in the kidneys to form calcitriol (1,25-dihydroxyvitamin D), the biologically active hormonal form.
Calcitriol acts through vitamin D receptors (VDR) found in virtually every tissue in the body. In the intestine, it stimulates the absorption of dietary calcium and phosphate. In bone, it works alongside parathyroid hormone (PTH) to regulate the release and deposition of calcium, ensuring proper mineralization of the bone matrix. In the kidneys, it promotes the reabsorption of calcium from the urine back into the bloodstream. These combined actions are critical for maintaining serum calcium levels within the narrow range required for normal nerve, muscle, and cardiac function.
Beyond its well-established role in bone metabolism, emerging research has identified vitamin D receptors in immune cells, muscle tissue, the brain, the pancreas, and the cardiovascular system. This has led to extensive investigation into the potential roles of vitamin D in immune modulation, infection prevention, cardiovascular health, glucose regulation, and cancer risk reduction. While observational studies have shown associations between low vitamin D levels and numerous chronic diseases, large randomized controlled trials such as the VITAL study (Manson et al., NEJM 2019) have not demonstrated significant benefits of routine vitamin D supplementation for preventing cardiovascular events or cancer in the general population without deficiency.
The World Health Organization estimates that approximately 1 billion people worldwide have vitamin D deficiency or insufficiency. Risk factors include living at latitudes above 35°N or below 35°S, having darker skin pigmentation, spending limited time outdoors, covering the skin for cultural or religious reasons, being elderly with reduced skin synthesis capacity, obesity (vitamin D is sequestered in fat tissue), and malabsorption disorders such as celiac disease, Crohn's disease, and cystic fibrosis.
Prescription-strength vitamin D3 at 800 IU (20 micrograms) per tablet is indicated primarily for the prevention and treatment of documented vitamin D deficiency in adults and adolescents over 12 years of age. It is also widely prescribed as an adjunct to specific osteoporosis treatments, where adequate calcium and vitamin D status is essential for anti-resorptive and anabolic bone therapies to work effectively. Common brand names include Divisun, Divifarm, Colecalciferol Viatris, and Colecalciferol EQL Pharma.
What Should You Know Before Taking Vitamin D3?
Before taking vitamin D3, you should be aware of several contraindications and precautions. Do not take vitamin D3 if you have hypercalcemia (elevated blood calcium), hypercalciuria (elevated urinary calcium), hypervitaminosis D, or kidney stones. Use with caution if you have sarcoidosis, impaired kidney function, or are taking other vitamin D-containing supplements.
Contraindications
You must not take vitamin D3 in the following circumstances:
- Allergy to cholecalciferol or any excipient: The tablets contain lactose monohydrate and sucrose among other inactive ingredients. If you have a known intolerance to these sugars, consult your healthcare provider before taking this medication
- Hypercalcemia: If you already have elevated blood calcium levels, taking additional vitamin D3 can worsen this condition, potentially leading to cardiac arrhythmias, kidney damage, and calcification of soft tissues
- Hypercalciuria: Elevated calcium in the urine increases the risk of kidney stone formation and kidney damage
- Hypervitaminosis D: If you already have excess vitamin D in the blood, further supplementation can lead to toxicity with serious consequences including irreversible kidney damage
- Kidney stones (nephrolithiasis): Vitamin D3 can increase calcium absorption and urinary calcium excretion, potentially worsening or triggering kidney stone formation in susceptible individuals
Warnings and Precautions
Talk to your healthcare provider before taking vitamin D3 if any of the following apply to you:
- Sarcoidosis: This inflammatory condition causes the formation of granulomas that can independently convert vitamin D to its active form (calcitriol), bypassing normal regulatory mechanisms. This can lead to uncontrolled calcium absorption and hypercalcemia, even with standard doses of vitamin D3. Patients with sarcoidosis should have their calcium levels monitored closely
- Other vitamin D-containing products: If you are already taking multivitamins, fortified foods, or other supplements that contain vitamin D, the combined intake should not exceed the tolerable upper intake level of 4,000 IU (100 micrograms) per day for adults, as set by the European Food Safety Authority (EFSA)
- Impaired kidney function: The kidneys are responsible for the final activation step of vitamin D. In chronic kidney disease, this conversion is impaired, and the use of cholecalciferol may be less effective. Additionally, patients with kidney disease are at greater risk of calcium imbalances. Your healthcare provider may need to monitor your blood calcium, phosphate, and parathyroid hormone levels more frequently
- History of kidney stones: Even if you do not currently have kidney stones, a history of calcium-containing stones warrants careful monitoring during vitamin D3 supplementation
The maximum daily dose of vitamin D3 should not exceed 4,000 IU (5 tablets of 800 IU). Higher doses should only be taken under medical supervision with regular monitoring of blood calcium levels. Chronic excessive intake can lead to vitamin D toxicity (hypervitaminosis D), characterized by hypercalcemia, which can cause nausea, vomiting, excessive thirst, frequent urination, constipation, muscle weakness, confusion, irregular heartbeat, and in severe cases, kidney failure and cardiac arrest.
Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, think you might be pregnant, or are planning to have a baby, consult your healthcare provider before taking vitamin D3.
During pregnancy, vitamin D3 should only be used when a deficiency has been confirmed by your healthcare provider. Many health authorities, including the WHO and NICE, recommend routine vitamin D supplementation of 400–600 IU daily during pregnancy to prevent deficiency. However, the daily intake should generally not exceed 600 IU during pregnancy unless specifically directed by a physician, as excessive vitamin D can theoretically affect fetal calcium metabolism. Some guidelines permit up to 4,000 IU under medical supervision for women with documented severe deficiency.
During breastfeeding, vitamin D3 can be used. Cholecalciferol passes into breast milk in small amounts. This should be considered if the breastfed infant is already receiving vitamin D supplementation, which is routinely recommended for all breastfed infants in many countries (typically 400 IU per day for the infant) to prevent rickets. Coordinate with your healthcare provider to ensure appropriate total vitamin D intake for both you and your baby.
Driving and Operating Machinery
Vitamin D3 has no known effects on the ability to drive or operate machinery. There are no reported cases of drowsiness, dizziness, or impaired cognitive function associated with standard doses of cholecalciferol. You do not need to take any special precautions regarding driving or machine use while taking this medication.
How Does Vitamin D3 Interact with Other Drugs?
Vitamin D3 can interact with several medications. Cholestyramine and orlistat reduce its absorption. Phenytoin and barbiturates increase its breakdown. Thiazide diuretics can increase the risk of high blood calcium when combined with vitamin D3. Corticosteroids may reduce its effectiveness, and cardiac glycosides (digoxin) carry an increased risk of arrhythmias if vitamin D3 causes elevated calcium.
Inform your healthcare provider about all medications you are currently taking, have recently taken, or might take. Drug interactions with vitamin D3 can affect its absorption, metabolism, or the risk of adverse effects. Understanding these interactions is important for safe and effective supplementation.
| Interacting Drug | Drug Class | Effect | Clinical Significance |
|---|---|---|---|
| Cholestyramine | Bile acid sequestrant | Reduces intestinal absorption of vitamin D3 by binding bile acids needed for fat-soluble vitamin absorption | Take vitamin D3 at least 2 hours before or 4–6 hours after cholestyramine |
| Phenytoin / Barbiturates | Anticonvulsant | Induces hepatic cytochrome P450 enzymes that accelerate the metabolism of vitamin D3, reducing its circulating levels | Higher vitamin D3 doses may be required; monitor 25(OH)D levels |
| Thiazide diuretics | Antihypertensive | Reduces renal calcium excretion, which combined with increased absorption from vitamin D3 can raise the risk of hypercalcemia | Monitor serum calcium levels regularly |
| Glucocorticoids | Corticosteroid | Reduce intestinal calcium absorption and may counteract the effects of vitamin D3 on bone metabolism | Higher vitamin D3 supplementation often required in chronic corticosteroid users |
| Digoxin / Digitoxin | Cardiac glycoside | Hypercalcemia induced by excessive vitamin D3 increases the risk of digitalis-related cardiac arrhythmias | Monitor serum calcium and digoxin levels closely |
| Orlistat | Lipase inhibitor (weight loss) | Reduces absorption of fat-soluble vitamins including vitamin D3 by inhibiting fat absorption | Take vitamin D3 at least 2 hours before or after orlistat |
| Actinomycin | Cytotoxic antibiotic | May interfere with the hepatic metabolism of vitamin D3 | Monitor vitamin D levels during chemotherapy |
| Imidazole antifungals | Antifungal | May inhibit the enzymatic conversion of vitamin D to its active form | Monitor 25(OH)D levels during prolonged antifungal therapy |
| Mineral oil laxatives | Laxative | Can reduce absorption of fat-soluble vitamins including vitamin D3 when used chronically | Avoid chronic use of mineral oil laxatives during vitamin D supplementation |
The interactions listed above are the most clinically significant. Many additional medications can affect vitamin D metabolism to a lesser degree. Always provide your healthcare provider with a complete list of all prescription medications, over-the-counter drugs, herbal supplements, and vitamins you are taking. This is particularly important if you are taking any calcium-containing supplements, as the combined effect with vitamin D3 on calcium levels needs to be considered.
What Is the Correct Dosage of Vitamin D3?
The standard recommended dose of vitamin D3 for adults is one 800 IU tablet taken once daily. Tablets can be swallowed whole or crushed and taken with or without food. The daily dose should not exceed 4,000 IU (5 tablets). Vitamin D3 in this formulation is not recommended for children under 12 years of age.
Always take this medication exactly as prescribed by your healthcare provider. If you are unsure about the correct dose, consult your healthcare provider or pharmacist. The appropriate dosage depends on the severity of your deficiency, your baseline vitamin D levels, your body weight, and any underlying medical conditions that may affect vitamin D metabolism.
Adults and Adolescents (12 years and older)
Standard Dosage
Recommended dose: 1 tablet (800 IU / 20 mcg) once daily
Maximum daily dose: 4,000 IU (5 tablets)
Administration: Swallow whole or crush. May be taken with or without food. Taking with a meal that contains some fat may enhance absorption.
For the prevention of vitamin D deficiency in healthy adults, the standard dose of 800 IU daily is generally sufficient for most individuals. This dose aligns with recommendations from the Endocrine Society, NICE, and the Institute of Medicine (now the National Academies of Sciences) for adults at risk of deficiency. For the treatment of documented vitamin D deficiency (serum 25(OH)D below 20 ng/mL or 50 nmol/L), your healthcare provider may prescribe higher initial loading doses followed by maintenance therapy at 800–2,000 IU daily.
Children (under 12 years)
Pediatric Use
This formulation (800 IU tablets) is not recommended for children under 12 years of age due to insufficient clinical trial data in this age group. For children, age-appropriate vitamin D3 formulations (drops or chewable tablets in lower strengths) should be used as directed by a pediatrician. Most guidelines recommend 400 IU daily for infants and young children.
Elderly Patients
Elderly Dosage
No specific dose adjustment is required for elderly patients. However, older adults are at particularly high risk of vitamin D deficiency due to reduced skin synthesis capacity, limited sun exposure, and decreased dietary intake. The Endocrine Society recommends at least 800–1,000 IU daily for adults over 65 to reduce the risk of falls and fractures. Your healthcare provider may recommend higher doses based on your individual blood levels.
Missed Dose
If you forget to take your daily dose of vitamin D3, simply take your next dose at the usual time. Do not take a double dose to make up for a missed one. Because vitamin D3 is fat-soluble and is stored in the body, missing an occasional dose is unlikely to have a significant clinical impact. However, consistent daily supplementation is recommended for optimal results.
Overdose
If you or someone else has taken a significantly larger amount of vitamin D3 than prescribed, contact your healthcare provider, go to the nearest emergency department, or call your local poison control center immediately. Vitamin D toxicity (hypervitaminosis D) is a potentially serious condition that typically develops with chronic daily intakes exceeding 10,000 IU over several months.
Excessive vitamin D intake causes hypercalcemia, which can present with: nausea and vomiting, loss of appetite, excessive thirst (polydipsia), increased urination (polyuria), constipation, abdominal pain, muscle weakness, fatigue, confusion and disorientation, irregular heartbeat, and in severe or prolonged cases, kidney damage (nephrocalcinosis) and calcium deposits in blood vessels and organs. Treatment involves discontinuation of vitamin D, a low-calcium diet, intravenous fluids, and in severe cases, corticosteroids or bisphosphonates to lower calcium levels.
What Are the Side Effects of Vitamin D3?
Side effects of vitamin D3 at recommended doses are uncommon. The most notable potential side effects are hypercalcemia (elevated blood calcium) and hypercalciuria (elevated urinary calcium), occurring in up to 1 in 100 users. Rare side effects include itching, rash, and hives. Seek immediate medical attention for signs of angioedema such as facial swelling, difficulty swallowing, or breathing difficulties.
Like all medicines, vitamin D3 can cause side effects, although not everybody gets them. Most people tolerate standard doses of cholecalciferol well, and side effects typically occur only with excessive intake or in predisposed individuals. The frequency of side effects is classified according to the following internationally standardized categories:
Uncommon
- Hypercalcemia – elevated calcium levels in the blood, which can cause nausea, constipation, abdominal pain, muscle weakness, fatigue, and confusion
- Hypercalciuria – elevated calcium levels in the urine, which increases the risk of kidney stone formation
Rare
- Pruritus (itching) – generalized or localized itching of the skin
- Skin rash – maculopapular or diffuse skin rash
- Urticaria (hives) – raised, itchy welts on the skin
Angioedema – swelling of the face, tongue, or throat; difficulty swallowing; hives combined with breathing difficulties. This is a rare but potentially life-threatening allergic reaction that requires emergency treatment. Call your local emergency number immediately.
If you develop symptoms of hypercalcemia such as persistent nausea, vomiting, excessive thirst, frequent urination, constipation, or unexplained fatigue while taking vitamin D3, contact your healthcare provider promptly. They may wish to check your serum calcium levels and adjust your dose accordingly. Hypercalcemia is more likely to occur with doses exceeding 4,000 IU per day or in patients with predisposing conditions such as sarcoidosis, certain cancers, or those taking thiazide diuretics.
Long-term excessive intake of vitamin D3 can lead to more serious consequences including nephrocalcinosis (calcium deposits in the kidneys), nephrolithiasis (kidney stones), ectopic calcification (calcium deposits in soft tissues such as blood vessels, heart valves, and lungs), and in extreme cases, renal failure. These complications are reversible in early stages if vitamin D supplementation is discontinued and appropriate treatment is initiated, but can become permanent if exposure continues.
Reporting Side Effects
If you experience any side effects, including those not listed above, talk to your healthcare provider or pharmacist. You can also help improve drug safety by reporting suspected side effects to your national pharmacovigilance authority (e.g., the FDA MedWatch program in the United States, the MHRA Yellow Card scheme in the United Kingdom, or the EMA EudraVigilance system in the European Union). Reporting adverse drug reactions helps regulatory authorities continuously monitor the benefit-risk balance of medicines.
How Should You Store Vitamin D3?
Store vitamin D3 tablets at or below 25°C (77°F) in the original packaging. Keep the blisters in the outer carton to protect from light. If supplied in a tablet container, keep the container tightly closed. Store out of the sight and reach of children. Do not use after the expiry date printed on the packaging.
Proper storage of vitamin D3 is important to maintain the potency and safety of the medication. Cholecalciferol is sensitive to light and can degrade when exposed to direct sunlight or strong artificial light for prolonged periods. Follow these storage guidelines:
- Temperature: Store at or below 25°C (77°F). Do not freeze. Avoid storing in hot environments such as car glove compartments or near radiators
- Light protection: Keep the blister strips in the original outer carton at all times. If the tablets are supplied in a plastic container, keep the container tightly closed to protect from light
- Moisture: Keep in a dry place. Avoid storing in the bathroom or other humid environments
- Child safety: Store out of the sight and reach of children. Consider using a locked medicine cabinet
- Expiry date: Do not use this medicine after the expiry date stated on the carton and blister after “EXP.” The expiry date refers to the last day of that month
Do not dispose of medications down the drain or in household waste. Ask your pharmacist about how to properly dispose of medicines you no longer use. These measures help protect the environment from pharmaceutical contamination of waterways and soil.
What Does Vitamin D3 Contain?
Each vitamin D3 tablet contains 20 micrograms of cholecalciferol, equivalent to 800 IU of vitamin D3 as the active ingredient. The tablets also contain several inactive ingredients (excipients) including lactose monohydrate, cellulose, modified starch, maize starch, and various coating agents.
Active Ingredient
The active substance is cholecalciferol (colecalciferol) 20 micrograms, equivalent to 800 IU (International Units) of vitamin D3. This is the same form of vitamin D that your body naturally produces when skin is exposed to sunlight, making it highly bioavailable and effective at raising serum 25(OH)D levels.
Inactive Ingredients (Excipients)
The tablets contain the following inactive ingredients:
- Tablet core: Lactose monohydrate, cellulose powder, modified food starch, maize starch, croscarmellose sodium, sucrose, colloidal anhydrous silica, magnesium stearate, sodium ascorbate, medium-chain triglycerides, all-rac-α-tocopherol
- Film coating: Poly(vinyl alcohol), titanium dioxide (E171), macrogol, talc, quinoline yellow aluminium lake (E104), yellow iron oxide (E172)
This medicine contains lactose and sucrose. If you have been told by your healthcare provider that you have an intolerance to certain sugars, contact them before taking this medicine. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, glucose-galactose malabsorption, or fructose intolerance should not take this medicine.
Appearance and Packaging
Vitamin D3 800 IU tablets are typically yellow-colored, round, approximately 6.1 mm in diameter, film-coated with a smooth, convex surface on both sides. They are available in the following pack sizes:
- 90 or 100 tablets in opaque PVC/PVdC-aluminium blisters
- 250 tablets in a plastic container with outer carton
Not all pack sizes may be marketed in your country. The specific brand appearance may vary between manufacturers (Divisun, Divifarm, Colecalciferol Viatris, Colecalciferol EQL Pharma), but the active ingredient content and quality standards remain the same across all authorized products.
Frequently Asked Questions About Vitamin D3
Vitamin D3 (cholecalciferol) is used to prevent and treat vitamin D deficiency in adults and adolescents. It regulates the absorption and metabolism of calcium and phosphate, and promotes the deposition of calcium in bone tissue. It is also commonly prescribed as an adjunct to osteoporosis treatment to ensure that anti-resorptive therapies (such as bisphosphonates or denosumab) can work effectively. The standard prescription dose is 800 IU (20 micrograms) taken once daily.
Yes, it is possible to take too much vitamin D3. The tolerable upper intake level for adults is 4,000 IU (100 micrograms) per day according to the European Food Safety Authority. Chronic intake above 10,000 IU per day can lead to vitamin D toxicity (hypervitaminosis D), causing dangerously high blood calcium levels (hypercalcemia). Symptoms include nausea, vomiting, excessive thirst, frequent urination, muscle weakness, confusion, and potentially kidney damage. If you suspect an overdose, contact your healthcare provider or poison control center immediately.
Side effects at recommended doses are uncommon. Hypercalcemia (elevated blood calcium) and hypercalciuria (elevated urinary calcium) may occur in up to 1 in 100 users. Rare side effects (up to 1 in 1,000 users) include itching, skin rash, and hives. Seek immediate emergency care if you experience swelling of the face, tongue, or throat, difficulty swallowing, or breathing difficulties, as these could indicate a serious allergic reaction (angioedema).
Vitamin D3 tablets can be taken with or without food. However, since vitamin D3 is a fat-soluble vitamin, taking it with a meal that includes some dietary fat (such as olive oil, butter, nuts, or avocado) may enhance its absorption. The tablets can be swallowed whole or crushed if you have difficulty swallowing. Try to take your tablet at approximately the same time each day to help you remember.
Vitamin D3 supplementation typically begins raising blood levels of 25-hydroxyvitamin D within 1 to 2 weeks. However, it generally takes 6 to 8 weeks of consistent daily supplementation to reach optimal steady-state levels. Your healthcare provider may check your vitamin D blood levels (serum 25(OH)D) after approximately 3 months of treatment to assess whether the dose is adequate. For patients with severe deficiency, higher loading doses may be prescribed initially, and it can take 3 to 6 months to fully replete vitamin D stores.
You should not take vitamin D3 if you have hypercalcemia (elevated blood calcium), hypercalciuria (elevated urinary calcium), hypervitaminosis D (vitamin D toxicity), or kidney stones. People with sarcoidosis should exercise particular caution, as this condition can cause unregulated activation of vitamin D, potentially leading to dangerously high calcium levels. Those with severe kidney disease should consult their healthcare provider, as the kidneys may not be able to properly activate vitamin D. Additionally, people with a known allergy to cholecalciferol or any of the tablet excipients (including lactose and sucrose) should avoid this medication.
References
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(7):1907-1947. doi:10.1210/clinem/dgae290
- Manson JE, Cook NR, Lee IM, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019;380(1):33-44. doi:10.1056/NEJMoa1809944
- National Institute for Health and Care Excellence (NICE). Vitamin D: supplement use in specific population groups. Public Health Guideline [PH56]. Updated 2024. nice.org.uk/guidance/ph56
- European Food Safety Authority (EFSA). Dietary Reference Values for Vitamin D. EFSA Journal. 2016;14(10):e04547. doi:10.2903/j.efsa.2016.4547
- World Health Organization (WHO). Vitamin D supplementation in specific population groups. WHO Guidelines. 2023. who.int/publications
- European Medicines Agency (EMA). Colecalciferol – Summary of Product Characteristics. 2024. ema.europa.eu
- Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40-49. doi:10.1056/NEJMoa1109617
- Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. J Clin Endocrinol Metab. 2011;96(1):53-58. doi:10.1210/jc.2010-2704
- British National Formulary (BNF). Colecalciferol. Accessed 2025. bnf.nice.org.uk
- Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr Rev. 2019;40(4):1109-1151. doi:10.1210/er.2018-00126
Editorial Team
This article has been written and reviewed by qualified medical professionals following international clinical guidelines and the GRADE evidence framework.
iMedic Medical Editorial Team
Licensed physicians with specializations in clinical pharmacology, endocrinology, and internal medicine. All content is based on peer-reviewed research and international guidelines from WHO, EMA, FDA, NICE, and the Endocrine Society.
iMedic Medical Review Board
Independent panel of board-certified medical specialists who review all content for accuracy, completeness, and adherence to current evidence-based practice guidelines. Conflicts of interest: none declared.